Literature DB >> 30354985

Plasma Heme Oxygenase-1 Levels and Carotid Atherosclerosis.

Yoshimi Kishimoto1, Kenji Sasaki2, Emi Saita1, Hanako Niki2, Reiko Ohmori3, Kazuo Kondo1,4, Yukihiko Momiyama2.   

Abstract

Background and Purpose- Heme oxygenase-1 (HO-1) catalyzes the oxidation of heme to generate carbon monoxide, biliverdin, and iron. Because these products have antiatherogenic properties, HO-1 may play a protective role against atherosclerosis. However, plasma HO-1 levels in patients with carotid atherosclerosis have not been reported. Methods- We investigated plasma HO-1 levels by ELISA in 136 subjects (age, 66±9 years) undergoing carotid ultrasonography. Results- Of the 136 study subjects, carotid plaque was found in 61 subjects (45%). Compared with 75 subjects without plaque, 61 with plaque were older and predominantly male ( P<0.05). Plasma HO-1 levels were higher in subjects with plaque than in those without plaque (median, 0.56 versus 0.44 ng/mL; P<0.05). The percentage of subjects with HO-1 level >0.50 ng/mL was higher in subjects with plaque than without plaque (66% versus 44%; P<0.025). In multivariate analysis, HO-1 level was a significant factor for carotid plaque independent of atherosclerotic risk factors. Odds ratio for plaque was 2.33 (95% CI, 1.15-4.75) for HO-1 level >0.50 ng/mL. Conclusions- Plasma HO-1 levels were high in subjects with carotid plaques, probably reflecting a protective response against carotid atherosclerosis.

Entities:  

Keywords:  atherosclerosis; biliverdine; carbon monoxide; carotid artery diseases; heme oxygenase-1

Mesh:

Substances:

Year:  2018        PMID: 30354985     DOI: 10.1161/STROKEAHA.118.022256

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

Review 1.  Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.

Authors:  John A McClung; Lior Levy; Victor Garcia; David E Stec; Stephen J Peterson; Nader G Abraham
Journal:  Pharmacol Ther       Date:  2021-09-06       Impact factor: 12.310

2.  Examining the expression levels of ferroptosis-related genes in angiographically determined coronary artery disease patients.

Authors:  Aybike Sena Ozuynuk; Aycan Fahri Erkan; Neslihan Coban; Nihan Unaltuna
Journal:  Mol Biol Rep       Date:  2022-05-27       Impact factor: 2.742

3.  Increased Plasma Heme Oxygenase-1 Levels in Patients With Early-Stage Parkinson's Disease.

Authors:  Wenhua Sun; Jinhua Zheng; Jianjun Ma; Zhidong Wang; Xiaoxue Shi; Mingjian Li; Shen Huang; Shiyu Hu; Zhenxiang Zhao; Dongsheng Li
Journal:  Front Aging Neurosci       Date:  2021-02-12       Impact factor: 5.750

4.  Induction of Heme Oxygenase-1 Is Linked to the Severity of Disease in Human Abdominal Aortic Aneurysm.

Authors:  Anja Hofmann; Margarete Müglich; Steffen Wolk; Yazan Khorzom; Pamela Sabarstinski; Irakli Kopaliani; Dmitry Egorov; Franziska Horn; Coy Brunssen; Sindy Giebe; Bianca Hamann; Andreas Deussen; Henning Morawietz; David M Poitz; Christian Reeps
Journal:  J Am Heart Assoc       Date:  2021-10-08       Impact factor: 5.501

Review 5.  The non-canonical effects of heme oxygenase-1, a classical fighter against oxidative stress.

Authors:  Jiajia Wu; Siyu Li; Cheng Li; Liying Cui; Jiajia Ma; Yang Hui
Journal:  Redox Biol       Date:  2021-10-20       Impact factor: 11.799

6.  Identification of potential drug targets for vascular dementia and carotid plaques by analyzing underlying molecular signatures shared by them.

Authors:  Jun Shu; Yiqing Ren; Wen Tan; Wenshi Wei; Li Zhang; Jie Chang
Journal:  Front Aging Neurosci       Date:  2022-10-03       Impact factor: 5.702

7.  Electronic and Tobacco Cigarettes Alter Polyunsaturated Fatty Acids and Oxidative Biomarkers.

Authors:  Rajat Gupta; Yan Lin; Karla Luna; Anjali Logue; Alexander J Yoon; Kacey P Haptonstall; Roya Moheimani; Yasmine Choroomi; Kevin Nguyen; Elizabeth Tran; Yifang Zhu; Kym F Faull; Theodoros Kelesidis; Jeffrey Gornbein; Holly R Middlekauff; Jesus A Araujo
Journal:  Circ Res       Date:  2021-06-30       Impact factor: 23.213

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.